The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity

키워드

참고문헌 (35)

1. Kensler TW, "Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway", Annu Rev Pharmacol Toxicol, 47, pp.89~116 (2007)
2. Itoh K, "Discovery of the negative regulator of Nrf2, Keap1: a historical overview", Antioxid Redox Signal, 13, pp.1665~1678 (2010)
3. Taguchi K, "Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution", Genes Cells, 16, pp.123~140 (2011)
4. Itoh K, "Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain", Genes Dev, 13, pp.76~86 (1999)
5. Bae SH, "Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage", Cell Metab, 17, pp.73~84 (2013)
6. Bataille AM, "Nrf2: a potential target for new therapeutics in liver disease", Clin Pharmacol Ther, 92, pp.340~348 (2012)
7. Musso G, "Nonalcoholic steatohepatitis: emerging molecular targets and therapeutic strategies", Nat Rev Drug Discov, 15, pp.249~274 (2016)
8. Johnson JA, "The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration", Ann N Y Acad Sci, 1147, pp.61~69 (2008)
9. Zoja C, "The Nrf2 pathway in the progression of renal disease", Nephrol Dial Transplant, 29(Suppl 1), pp.i19~i24 (2014)
10. Goligorsky MS, "Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil", Kidney Int, 27, pp.774~779 (1985)
11. Rosei EA, "Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators", J Hypertens, 15, pp.1337~1344 (1997)
12. Pajak B, "Verapamil-induced autophagy-like process in colon adenocarcinoma COLO 205 cells; the ultrastructural studies", Pharmacol Rep, 64, pp.991~996 (2012)
13. Park HW, "Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers.", Nat Commun, 5, pp.4834~ (2014)
14. Park HW, "Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies", Autophagy, 10, pp.2385~2386 (2014)
15. James LP, "Acetaminophen- induced hepatotoxicity", Drug Metab Dispos, 31, pp.1499~1506 (2003)
16. Ni HM, "Targeting autophagy for the treatment of liver diseases", Pharmacol Res, 66, pp.463~474 (2012)
17. Copple IM, "The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system", Hepatology, 48, pp.1292~1301 (2008)
18. Li N, "Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals", J Immunol, 173, pp.3467~3481 (2004)
19. Taguchi K, "Keap1 degradation by autophagy for the maintenance of redox homeostasis", Proc Natl Acad Sci U S A, 109, pp.13561~13566 (2012)
20. Komatsu M, "The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1", Nat Cell Biol, 12, pp.213~223 (2010)
21. Ichimura Y, "Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy", Mol Cell, 51, pp.618~631 (2013)
22. Hinson JA, "Mechanisms of acetaminophen-induced liver necrosis", Handb Exp Pharmacol, pp.369~405 (2010)
23. McGill MR, "The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation", J Clin Invest, 122, pp.1574~1583 (2012)
24. Goldring CE, "Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice", Hepatology, 39, pp.1267~1276 (2004)
25. Chan K, "An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen", Proc Natl Acad Sci U S A, 98, pp.4611~4616 (2001)
26. McMahon M, "Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex", J Biol Chem, 281, pp.24756~24768 (2006)
27. (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL, "6J mice", Diabetologia, 54, pp.922~934 (2011)
28. Katsuragi Y, "p62", SQSTM1 functions as a signaling hub and an autophagy adaptor, 2015, pp.282, 4672~4678
29. Lau A, "A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62", Mol Cell Biol, 30, pp.3275~3285 (2010)
30. Lee DH, "Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis", Free Radic Biol Med, 99, pp.520~532 (2016)
31. Sarkar S, "Regulation of autophagy by mTORdependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers", Biochem Soc Trans, 41, pp.1103~1130 (2013)
32. Schmieder RE, "Cardiovascular effects of verapamil in patients with essential hypertension", Circulation, 75, pp.1030~1036 (1987)
33. Prescott LF, "The treatment of acetaminophen poisoning", Annu Rev Pharmacol Toxicol, 23, pp.87~101 (1983)
34. Jiang J, "Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain", Toxicol Lett, 234, pp.139~150 (2015)
35. Liu J, "Nrf2 protection against liver injury produced by various hepatotoxicants", Oxid Med Cell Longev, 2013, pp.305861~ (2013)

관련 논문AI추천